skip to main content

Ncardia

Cell models from induced pluripotent stem cells

Ncardia develops a wide range of in-vitro cell models from human induced pluripotent stem cells. These cell models are used for research into the safety and effectiveness of drugs and as the basis of cell therapy.

Ncardia is using Mibiton funding to purchase an ImageXpress Micro Confocal High-Content Imaging System, which can measure a wide range of cellular phenotypes.

Stefan Braam, CEO

"Mibiton's investment allowed us to improve our analytical technology, which tests the safety and effectiveness of drugs based on human cell models."

Winner Mibiton Certificate 2022